⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for vain2

Every month we try and update this database with for vain2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesNCT05372016
HPV Infections
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN3
VaIN1
VaIN2
VaIN3
Genital Wart
VIN 1
VIN 2
VIN 3
AIS
Experimental: E...
Active Comparat...
16 Years - 26 YearsShanghai Bovax Biotechnology Co., Ltd.
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesNCT03676101
Cervical Cancer...
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN 3
AIS
Invasive Carcin...
Mild Dysplasia ...
Moderate Dyspla...
Vin III
VaIN1
VaIN2
VaIN3
Genital Wart
9-valent HPV Re...
Placebo
9 Years - 45 YearsShanghai Bovax Biotechnology Co., Ltd.
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesNCT04425291
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN3
VaIN1
VaIN2
VaIN3
Genital Wart
VIN 1
VIN 2
VIN 3
AIS
4-valent HPV Va...
9-valent HPV Va...
GARDASIL®
20 Years - 45 YearsShanghai Bovax Biotechnology Co., Ltd.
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 YearsNCT04895020
HPV Infections
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN 3
VaIN1
VaIN2
VaIN3
Genital Wart
VIN 1
VIN 2
VIN 3
AIS
9-valent HPV va...
9 Years - 45 YearsShanghai Bovax Biotechnology Co., Ltd.
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesNCT03676101
Cervical Cancer...
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN 3
AIS
Invasive Carcin...
Mild Dysplasia ...
Moderate Dyspla...
Vin III
VaIN1
VaIN2
VaIN3
Genital Wart
9-valent HPV Re...
Placebo
9 Years - 45 YearsShanghai Bovax Biotechnology Co., Ltd.
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesNCT05372016
HPV Infections
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN3
VaIN1
VaIN2
VaIN3
Genital Wart
VIN 1
VIN 2
VIN 3
AIS
Experimental: E...
Active Comparat...
16 Years - 26 YearsShanghai Bovax Biotechnology Co., Ltd.
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesNCT04422366
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
CIN1
CIN2
CIN3
VaIN1
VaIN2
VaIN3
Genital Wart
VIN 1
VIN 2
VIN 3
AIS
9-valent Human ...
GARDASIL®
20 Years - 45 YearsShanghai Bovax Biotechnology Co., Ltd.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: